KEELE, England, Dec. 15, 2021 /PRNewswire/ — Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue, is pleased to provide the following business update … Enhanced approval for STIMULAN in Canada and Saudi Arabia … In 2021, STIMULAN® products gained a new approval in Canada for mixing with antibiotics: vancomycin, gentamicin and tobramycin, for use in treating bacterial infection in soft tissue surrounding bone. This was followed by a new approval in Saudi Arabia for STIMULAN® to be mixed with antibiotics for use in bone and soft tissue … STIMULAN® is the only calcium matrix antibiotic carrier with an EU approval for use in bone and soft tissue and offers surgeons the flexibility to apply broad spectrum ‘off-the-shelf’ antibiotics at concentrations that will support their patient-specific treatment plans – dramatically improving patient outcomes and redefining standard of care … read more